A. H. van Gennip
- Molecular Biology top 5%
- Clinical Biochemistry top 0.2%
- Oncology top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Physiology top 10%
- Co-authors
- André B. P. KuilenburgP. VrekenRonald J. A. WandersHenk van LentheHenk OvermarsN.G.G.M. AbelingM. DuránLodewijk IJlst
- Topics
- Biochemical and Molecular Research (34 papers)Metabolism and Genetic Disorders (32 papers)Neonatal Health and Biochemistry (16 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
A. H. van Gennip
82 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 1.7k
- Clinical Biochemistry 840
- Oncology 829
- Pediatrics, Perinatology and Child Health 303
- Physiology 257
Countries citing papers authored by A. H. van Gennip
This map shows the geographic impact of A. H. van Gennip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. van Gennip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. van Gennip more than expected).
Fields of papers citing papers by A. H. van Gennip
This network shows the impact of papers produced by A. H. van Gennip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. van Gennip. The network helps show where A. H. van Gennip may publish in the future.
Co-authorship network of co-authors of A. H. van Gennip
This figure shows the co-authorship network connecting the top 25 collaborators of A. H. van Gennip. A scholar is included among the top collaborators of A. H. van Gennip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. van Gennip. A. H. van Gennip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 8 | |
| 3 | 58 | |
| 4 | 39 | |
| 5 | 8 | |
| 6 | 2 | |
| 7 | 17 | |
| 8 | Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. | 307 |
| 9 | 29 | |
| 10 | 18 | |
| 11 | 12 | |
| 12 | 29 | |
| 13 | 81 | |
| 14 | Specification of the inhibitory action of MIBG on the respiratory chain by EPR scanning. | 1 |
| 15 | 4 | |
| 16 | 114 | |
| 17 | 104 | |
| 18 | 15 | |
| 19 | Imbalance between the pyrimidine ribonucleotide pools of rat pheochromocytoma PC-12 cells | 8 |
| 20 | 1 |
About A. H. van Gennip
A. H. van Gennip is a scholar working on Clinical Biochemistry, Molecular Biology and Biochemistry, having authored 82 papers that have together received 2.8k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (34 papers), Metabolism and Genetic Disorders (32 papers) and Neonatal Health and Biochemistry (16 papers). The work is most often cited by research in Clinical Biochemistry (840 citations), Biochemistry (229 citations) and Oncology (829 citations). A. H. van Gennip has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include André B. P. Kuilenburg, P. Vreken, Ronald J. A. Wanders, Henk van Lenthe, Henk Overmars, N.G.G.M. Abeling, M. Durán, Lodewijk IJlst, Albert H. Bootsma and Frits A. Wijburg. Their work appears in journals such as Journal of Clinical Investigation, Analytical Biochemistry and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.